SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-035455
Filing Date
2014-11-04
Accepted
2014-11-04 17:25:41
Documents
2
Period of Report
2014-11-01

Document Format Files

Seq Description Document Type Size
1 YOUSSOUFIAN F3 rrd418210.html 3  
1 YOUSSOUFIAN F3 rrd418210.xml 3 1608
2 POWER OF ATTORNEY rrd376588_426718.htm EX-24. 4962
  Complete submission text file 0001181431-14-035455.txt   8110
Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Issuer) CIK: 0001385228 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NAVY YARD PLAZA ONE FIRST AVENUE, PARRIS BUILDING #34 BOSTON MA 02129
Business Address
Youssoufian Hagop (Reporting) CIK: 0001525899 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36072 | Film No.: 141194264